Cell Biotech Co., Ltd. (KOSDAQ:049960)
South Korea
· Delayed Price · Currency is KRW 12,590
-60 (-0.47%)
At close: Mar 31, 2025, 3:30 PM KST
Cell Biotech Revenue
In the year 2024, Cell Biotech had annual revenue of 49.91B KRW, down -7.20%. Cell Biotech had revenue of 12.16B in the quarter ending December 31, 2024, a decrease of -18.10%.
Revenue
49.91B
Revenue Growth
-7.20%
P/S Ratio
1.73
Revenue / Employee
449.66M
Employees
111
Market Cap
86.16B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 49.91B | -3.87B | -7.20% |
| Dec 31, 2023 | 53.79B | 3.26B | 6.46% |
| Dec 31, 2022 | 50.53B | 3.65B | 7.79% |
| Dec 31, 2021 | 46.87B | 1.29B | 2.83% |
| Dec 31, 2020 | 45.58B | -377.42M | -0.82% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Electronics | 300.87T |
| SK hynix | 66.19T |
| LG Energy Solution | 25.62T |
| Samsung Biologics | 4,547.32B |
| Hyundai Motor Company | 175.23T |
| Celltrion | 3,557.30B |
| Kia Corporation | 107.45T |
| KB Financial Group | 15.01T |